Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$89,856,006
+$14,611,675 QoQ
Shares Held
5,658,439
+1.6% QoQ
Ownership
0.493%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#31
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
This page
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,856,006 | 5,658,439 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $75,244,331 | 5,569,529 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $11,313,112 | 908,684 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $8,134,916 | 821,709 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,375,435 | 825,917 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,896,271 | 1,136,197 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,864,224 | 952,950 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $11,775,568 | 1,014,261 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $9,432,665 | 887,363 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,022,613 | 755,663 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,664,042 | 707,668 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,516,039 | 762,276 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,027,446 | 403,552 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,285,266 | 445,454 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,784,821 | 340,056 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,486,124 | 291,799 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,082,795 | 294,441 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,047,263 | 96,256 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,206,535 | 89,175 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,415,308 | 104,451 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,608,667 | 112,573 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,981,670 | 141,852 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $33,154,392 | 1,769,178 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||